Smart pens and telemedicine aim to tame diabetes in veterans

NCT ID NCT06918977

Recruiting now Disease control Sponsor: University of Maryland, Baltimore Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether using a smart insulin pen (InPen) along with a continuous glucose monitor and telemedicine can improve blood sugar control in veterans with type 2 diabetes who take multiple daily insulin injections. Fifty participants will be randomly assigned to use either the smart pen or a traditional insulin pen, both with telemedicine support. The main goal is to see if the smart pen leads to a greater drop in HbA1c, a key measure of blood sugar control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Smart insulin pen (InPen) with continuous glucose monitor and telemedicine
What this could lead to: If successful, this could show that combining smart insulin pens with telemedicine helps people with type 2 diabetes achieve better blood sugar control and fewer complications.
What could go wrong: This is a small, early-stage study with only 50 participants, so results may not apply to everyone. The smart pen relies on user input and technology, which could lead to errors or be less effective in some patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS

Contacts and locations

Locations

Baltimore VA Maryland Center
RECRUITING

Baltimore, Maryland, 21201, United States
VAMHCS, Diabetes Outpatient Clinic
NOT_YET_RECRUITING

Baltimore, Maryland, 21201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.